Bare Platinum Coils Versus Second-generation Hydrocoils

Sponsor
Seoul National University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04988503
Collaborator
Pusan National University Yangsan Hospital (Other), Chungnam National University Sejong Hospital (Other)
118
3
2
28
39.3
1.4

Study Details

Study Description

Brief Summary

Comparison of clinical and radiological outcomes between bare platinum coil group and second-generation hydrogel coils for treatment of ruptured intracranial aneurysms.

Condition or Disease Intervention/Treatment Phase
  • Device: Coil embolization
N/A

Detailed Description

The investigators aimed to analyze whether the use of second-generation hydrogel coils for the treatment of ruptured intracranial aneurysms improves clinical and angiographic outcomes compared with the use of bare platinum coils.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
118 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
bare platinum coils group versus second-generation hydrogel coil groupbare platinum coils group versus second-generation hydrogel coil group
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Bare Platinum Coils Versus Second-generation Hydrocoils for the Endovascular Treatment of Ruptured Intracranial Aneurysms: a Randomized Controlled Study
Actual Study Start Date :
Aug 30, 2021
Anticipated Primary Completion Date :
Aug 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Second-generation hydrogel coil group

Treatment using second-generation hydrogel coils (had to constitute > 50% of the total coil length) for ruptured cerebral aneurysms

Device: Coil embolization
coil embolization for ruptured intracranial aneurysm with bare platinum coils or second-generation hydrogel coils

Active Comparator: Bare platinum coil group

Treatment using bare metal coil only for ruptured cerebral aneurysms

Device: Coil embolization
coil embolization for ruptured intracranial aneurysm with bare platinum coils or second-generation hydrogel coils

Outcome Measures

Primary Outcome Measures

  1. recurrence rate after treatment [during 12 months after coil embolization]

    recurrence rate at 12 months after coil embolization

Secondary Outcome Measures

  1. Rates of thromboembolic and hemorrhagic complications [during 12 months after coil embolization]

    Rates of thromboembolic and hemorrhagic complications

  2. Rate of periprocedural complications [within 30 days after coil embolization]

    Rate of periprocedural complications

  3. Assessment of clinical outcomes using modified Rankin Scale scores [during 12 months after coil embolization]

    Modified Rankin Scale scores (0-6, higher scores mean a worse outcome)

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 19 year old or older

  • untreated ruptured intracranial aneurysms with an anatomy such that endovascular treatment with either bare platinum or second-generation hydrogel coils was considered feasible.

  • person who agreed to study

Exclusion Criteria:
  • contrast allgery (+)

  • combined other intracranial lesions (tumor, moyamoya disease, cerebral vascular diseases)

  • ineligible for coil embolization

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chungnam National University Sejong Hospital Sejong Chungnam Korea, Republic of 30099
2 Pusan National University Yangsan Hospital Yangsan Gyeongsangnam-do Korea, Republic of 50612
3 Seoul National University Bundang Hospital Seongnam-si Korea, Republic of 13620

Sponsors and Collaborators

  • Seoul National University Hospital
  • Pusan National University Yangsan Hospital
  • Chungnam National University Sejong Hospital

Investigators

  • Principal Investigator: O-Ki Kwon, Seoul National University Bundang Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT04988503
Other Study ID Numbers:
  • B-2012/652-002
First Posted:
Aug 3, 2021
Last Update Posted:
Jul 7, 2022
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Seoul National University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 7, 2022